Track B

B8 Patient Samples: To Transfer or Not to Transfer?

Track: Nuts and Bolts of Technology Transfer

Target Audience: All Audiences

Hilary Eaton, Dana-Farber Cancer Institute

Susie Airhart, Jackson Labs
Thomas Broudy, Crown Bioscience
Janis Elsner, Vanderbilt
Barbara Gamez-Sims, Mayo Clinic

Many institutions have recently established policies or guidelines regarding the transfer of human tissue or patient-derived materials to external parties (both academic and industry) for research use, and technology transfer offices must conform to these in negotiating Material Transfer Agreements (MTAs), collaboration agreements and the like. During this interactive session, panelists from technology transfer offices affiliated with research hospitals and nonprofit institutes will discuss ethical and financial guidelines for handling outgoing patient sample transfer to industry partners. The discussion will include the particular challenges the institutions have encountered in structuring agreements and compensation for such transfers. Audience participation is encouraged. Join us for this hot topic!

Return to Schedule

AUTM 2016 Annual Meeting Sponsors